GILD vs MAC · P/E 18, rev $29.44B vs rev $918.2M
Gilead Sciences Inc (GILD) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MAC currently screens at market cap $4.41B.
Not investment advice. Open the GILD and MAC stock pages for the full models.
Not investment advice.